Prediction of the Therapeutic Effects of Pembrolizumab and Nivolumab in Advanced Non-Small Cell Lung Cancer by Platelet-Derived Microparticles in Circulating Blood

BACKGROUND: There are limited methods to predict the therapeutic effect of immune checkpoint inhibitors (ICIs). The purpose of this study was to explore the value of circulating microparticles (MPs) in predicting thetherapeutic effects of immunotherapy. METHODS: A prospective study was conducted at...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Wang, Jiang, Liu, Yanxin, Wu, Jionghe, Yuan, Yaping, Wang, Chao, Fang, Xiangqun, Li, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903816/
https://www.ncbi.nlm.nih.gov/pubmed/33612078
http://dx.doi.org/10.1177/1533033821997817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903816/
https://www.ncbi.nlm.nih.gov/pubmed/33612078
http://dx.doi.org/10.1177/1533033821997817

Ejemplares similares